Skip to main content
OpenTrials
Completed

NCT Number: NCT02627014

Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders

The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Migraine Craniomandibular Disorders Jaw Diseases Joint Diseases Mandibular Diseases Muscular Diseases Musculoskeletal Diseases Stomatognathic Diseases Temporomandibular Disorders Temporomandibular Joint Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidad San Jorge

Zaragoza, Spain

About this study

The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chronic migraine (ICHD_III beta, 2013)
  • Temporomandibular disorders (RDC/TMD)

Exclusion criteria

  • other neurological disease
  • psychiatric diseases
  • Physical therapy treatment in the last 6 months
  • dental treatment in the last 6 months
  • surgery or trauma in the orofacial region

Treatment and study plan

Manual therapy

Other

6 treatments: 2 treatments for week

1 treatment = 30 minutes

Home physical therapy

Other

once a day: 15 minutes

Manual therapy in cervical region

Other

6 treatments: 2 treatments for week

1 treatment = 30 minutes

Home physical therapy in cervical region

Other

once a day: 15 minutes

Primary outcomes

  1. Headache Impact Test (HIT-6)

    Time frame: 3 months

Secondary outcomes

  1. Visual Analogue Scale (VAS)

    Time frame: 3 months

  2. Quality of life (SF-36)

    Time frame: 3 months

  3. Sleep Quality

    Time frame: 3 months

    Pittsburgh Sleep Quality Index

  4. Pain threshold pressure

    Time frame: 3 months

    Pressure algometer in masticatory muscle (area trigeminal) and control point in area extra-trigeminal

  5. Pain catastrophizing scale (PCS)

    Time frame: 3 months

  6. Craniofacial Pain and Disability Inventory (CF-PDI)

    Time frame: 3 months

  7. Tampa scale of Kinesiophobia (TSK)

    Time frame: 3 months

  8. Tampa scale of Kinesiophobia of cranio-mandibular disorder (TSK-TCM)

    Time frame: 3 months

  9. Maximal Mouth Opening pain free

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Cardenal Herrera University

Other

Collaborators

  • Hospital Miguel Servet

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Dec 10, 2015
Registry last updated
Aug 8, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.